(ADAP) Adaptimmune Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Adaptimmune Therapeutics | (ADAP) share price targets
Complete technical analysis of Adaptimmune Therapeutics (ADAP) by charts plus indicators, forecast predictions and share price targets for Adaptimmune Therapeutics (ADAP)
Adaptimmune Therapeutics trades in USA in Health Care sector.
Showing technical analysis as on 2025-06-03 View latest technical analysis
10 day averaged volume of Adaptimmune Therapeutics is 490390
Date | Daily Closing Price | Open | High | Low | Volume |
03 Tue Jun 2025 | 0.29 | 0.28 | 0.29 | 0.28 | 0.935 times |
02 Mon Jun 2025 | 0.28 | 0.30 | 0.30 | 0.28 | 1.306 times |
30 Fri May 2025 | 0.29 | 0.28 | 0.29 | 0.26 | 1.419 times |
29 Thu May 2025 | 0.27 | 0.28 | 0.28 | 0.26 | 0.671 times |
28 Wed May 2025 | 0.27 | 0.28 | 0.29 | 0.27 | 0.552 times |
27 Tue May 2025 | 0.28 | 0.29 | 0.30 | 0.28 | 1.101 times |
23 Fri May 2025 | 0.28 | 0.27 | 0.29 | 0.26 | 0.793 times |
22 Thu May 2025 | 0.27 | 0.28 | 0.28 | 0.27 | 0.776 times |
21 Wed May 2025 | 0.28 | 0.28 | 0.30 | 0.27 | 0.67 times |
20 Tue May 2025 | 0.29 | 0.30 | 0.30 | 0.28 | 1.394 times |
My analysis of stock is bullish for shortterm, and stock might move up till 0.3 or till 0.3. Use a stoploss of 0.28 and if this stock hits its stoploss, then it can fall down till 0.27
Share price targets for Adaptimmune Therapeutics (ADAP)
Target Type | Value |
Downside Target | 0.20 |
Downside Target | 0.25 |
Downside Target | 0.26 |
Downside Target | 0.28 |
Downside Target | 0.29 |
Upside Target | 0.30 |
Upside Target | 0.32 |
Upside Target | 0.33 |
Upside Target | 0.51 |
Upside Target | 0.56 |
Upside Target | 0.62 |
Intraday share price targets for Adaptimmune Therapeutics (ADAP)
Target Type | Value |
Downside Intraday Target | 0.28 |
Downside Intraday Target | 0.27 |
Upside Intraday Target | 0.3 |
Upside Intraday Target | 0.31 |
Upside Intraday Target | 0.29 |
Weekly technical analysis of Adaptimmune Therapeutics (ADAP)
Date | Weekly Closing Price | Open | High | Low | Volume |
03 Tue Jun 2025 | 0.29 | 0.30 | 0.30 | 0.28 | 0.599 times |
30 Fri May 2025 | 0.29 | 0.29 | 0.30 | 0.26 | 0.756 times |
23 Fri May 2025 | 0.28 | 0.28 | 0.30 | 0.26 | 0.1 times |
16 Fri May 2025 | 0.28 | 0.30 | 0.33 | 0.25 | 6.889 times |
09 Fri May 2025 | 0.29 | 0.29 | 0.32 | 0.29 | 1.295 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Adaptimmune Therapeutics (ADAP)
Date | Monthly Closing Price | Open | High | Low | Volume |
03 Tue Jun 2025 | 0.29 | 0.30 | 0.30 | 0.28 | 0.033 times |
30 Fri May 2025 | 0.29 | 0.27 | 0.33 | 0.25 | 0.969 times |
30 Wed Apr 2025 | 0.28 | 0.20 | 0.33 | 0.20 | 0.788 times |
31 Mon Mar 2025 | 0.20 | 0.56 | 0.56 | 0.20 | 2.494 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Adaptimmune Therapeutics (ADAP)
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a short to mid term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Adaptimmune Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Adaptimmune Therapeutics in short term but the buy signal is initial and weak.
Adaptimmune Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting stronger in this stock.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be moving up
CCI has generated a SELL signal for Adaptimmune Therapeutics in short term
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Adaptimmune Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 0.28 and Adaptimmune Therapeutics (ADAP) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Adaptimmune Therapeutics (ADAP) stock. Volume based technical analysis of Adaptimmune Therapeutics (ADAP) stock is negative.
Adaptimmune Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a short to mid term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Adaptimmune Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Adaptimmune Therapeutics in short term but the buy signal is initial and weak.
Adaptimmune Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting stronger in this stock.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be moving up
CCI has generated a SELL signal for Adaptimmune Therapeutics in short term
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Adaptimmune Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 0.28 and Adaptimmune Therapeutics (ADAP) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Adaptimmune Therapeutics (ADAP) stock. Volume based technical analysis of Adaptimmune Therapeutics (ADAP) stock is negative.
Adaptimmune Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.